Evidence map›Paper›PMID 42681328›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Integration of Omics Data to Identify Cancer-Related MicroRNA.

Luciano Cascione

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Luciano CascioneInstitute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland. luciano.cascione@ior.usi.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that play critical regulatory roles in gene expression by targeting messenger RNAs (mRNAs) for degradation or translational inhibition. Their ability to modulate multiple genes simultaneously places them at the center of many biological processes, including those involved in tumorigenesis. Depending on their targets, miRNAs can act as oncogenes or tumor suppressors, contributing to cancer development and progression. Advances in high-throughput sequencing now allow simultaneous profiling of miRNA and mRNA expression in the same biological samples. When properly integrated, these datasets can uncover functional miRNA-mRNA regulatory networks, reveal cancer-specific signatures, and identify novel biomarkers or therapeutic targets. However, the integrative analysis of miRNA and mRNA expression data remains computationally challenging and requires well-structured pipelines and rigorous statistical approaches. In this chapter, we present updated computational strategies to identify biologically relevant miRNA-mRNA interactions through expression correlation, target prediction, and functional enrichment. The chapter includes step-by-step protocols, example R code, and recommendations for integrating additional data layers such as copy number variation and DNA methylation, with the goal of improving the robustness and interpretability of miRNA-based analyses in cancer.

Indexed as

Computational BiologyGenomicsMicroRNAsNeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMultiomicsRNA, MessengerSoftwareMicroRNAsRNA, MessengerBioinformatics pipelineCancerMicroRNAsmiRNA–mRNA regulatory networksMulti-omics integration

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.